Phase Ib, Randomized, Double-blind, Placebo-Controlled, Dose-Escalation Study of Alpha-0261 Tablets to Assess Safety and Tolerability in Patients With Chronic Spontaneous Urcaria (Part 1) and Food Effect in Healthy Adults (Part 2).
Clinical trial NCT07684560 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07684560
- Sponsor
- AlphaMol Science Ltd. (Shanghai)
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-01
- Primary completion
- 2027-03-30
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.